Acute renal artery and vein thrombosis after renal transplant, associated with a short partial thromboplastin time and factor V Leiden mutation

Annals of Clinical and Laboratory Science

Volumn 30, Issue 1, 2000, Pages 75-78

  Guirguis, Nabil ^a   Budisavljevic, Milos N ^a   Self, Sally ^a   Rajagopalan, P R ^a   Lazarchick, John ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cadaveric renal transplant; Factor V Leiden mutation; Renal artery thrombosis; Renal vein thrombosis; Short activated partial thromboplastin time

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENETIC RISK; GRAFT REJECTION; HEMODIALYSIS; HUMAN; HYPERCOAGULABILITY; KIDNEY GRAFT; KIDNEY VEIN THROMBOSIS; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RENAL ARTERY THROMBOSIS;

ACUTE DISEASE; ADULT; FACTOR V; FEMALE; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MUTATION; PARTIAL THROMBOPLASTIN TIME; PREDICTIVE VALUE OF TESTS; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; RENAL VEINS; TREATMENT FAILURE; VENOUS THROMBOSIS;

EID: 0033972833     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Gray D. Vascular and lymphatic complications after renal transplantation. In: Kidney Transplantation (Morris PJ ed), WW Saunders Company, Philadephia, 1994; pp 314-329.
2. Penny MJ, Nankivell BJ, Disney APS, Byth K, Chapman JR. Renal graft thrombosis. Transplantation 1994; 58:565-569.
3. Bakir N, Sluiter WJ, Ploeg RJ, van Son WJ, Tegzess AM. Primary renal graft thrombosis. Nephrol Dial Transplant 1996; 11:140-147.
4. Heidenreich S, Dereck C, August C, Koch HG, Nowak-Gotti U. High rate of acute rejection in renal allograft recipients with thrombophilic risk factors. J Am Soc Nephrol 1998; 9:1309-1313.
5. Hooper WC, Evatt BL. The role of activated protein C resistance in the pathogenesis of venous thrombosis. Am J Med Sci 1998; 316:120-128.
6. Laffan M, Tuddenham E. Assessing thrombotic risk. Br Med J 1998; 317:520-523.
7. Dahlback B. Resistance to activated protein C as risk factor for thrombosis. Semin Hematol 1997; 34:217-234.
8. 506→ Gln mutation in the gene for factor V (factor V Leiden). N Engl J Med 1997; 336:399-403.
9. Bick RL. Disseminated intravascular coagulation: pathophysiological mechanisms and manifestations. Semin Thromb Hemost 1998; 24:3-18.